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RNA represents a pivotal component of host–pathogen interac-
tions. Human cytomegalovirus (HCMV) infection causes extensive
alteration in host RNA metabolism, but the functional relationship
between the virus and cellular RNA processing remains largely
unknown. Through loss-of-function screening, we show that
HCMV requires multiple RNA-processing machineries for efficient
viral lytic production. In particular, the cellular RNA-binding pro-
tein Roquin, whose expression is actively stimulated by HCMV,
plays an essential role in inhibiting the innate immune response.
Transcriptome profiling revealed Roquin-dependent global down-
regulation of proinflammatory cytokines and antiviral genes in
HCMV-infected cells. Furthermore, using cross-linking immunopre-
cipitation (CLIP)-sequencing (seq), we identified IFN regulatory fac-
tor 1 (IRF1), a master transcriptional activator of immune responses,
as a Roquin target gene. Roquin reduces IRF1 expression by directly
binding to its mRNA, thereby enabling suppression of a variety of
antiviral genes. This study demonstrates how HCMV exploits host
RNA-binding protein to prevent a cellular antiviral response and
offers mechanistic insight into the potential development of CMV
therapeutics.
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Human cytomegalovirus (HCMV) is a member of theβ-herpesvirus family and a ubiquitous pathogen that estab-
lishes lifelong latency in large populations worldwide (1). During
primary infection of HCMV, which rarely exhibits pathogenic
symptoms in healthy humans, the virus overcomes innate and
adaptive immune responses in the host and establishes permanent
latency. Reactivation from latency can be dangerous in immune-
compromised hosts, with HCMV congenital infection being a
leading cause of neurological defects in infants (2–4). Currently,
there is no therapeutic intervention capable of curing chronic
HCMV infection, and no vaccines are available to prevent HCMV
infection. This is largely because of the multiple strategies employed
by HCMV to evade innate and adaptive immunity. Thus, having a
thorough understanding of how the virus evades the host immune
system is necessary for the development of anti-HCMV vaccines
and therapeutics.
Primary HCMV infection provokes a robust innate immune
response in terms of rapid induction of nuclear factor kappaB
(NF-κB)- and IFN regulatory factor (IRF)3-signaling pathways
in cells (5–7). Proinflammatory cytokines, type I interferons, and
IFN-stimulated genes (ISGs) are produced and confer antiviral
effects by targeting various steps of HCMV replication (8, 9).
However, HCMV has evolved strategies of regulating cellular
cytokines in order to counteract the host immune system. First,
HCMV encodes cellular cytokine mimics and decoy receptors in
order to modulate cytokine activity and restrict cell migration
and differentiation (10–15). Second, HCMV inhibits production
of cytokines by blocking the activation of transcription factors
(16–19). Third, viral microRNAs (miRNAs) directly target the
mRNAs of cellular chemokines and cytokines and posttranscrip-
tionally repress their expression. We previously reported that the
HCMV-encoded miRNA miR-UL148D down-regulates the
cellular chemokine RANTES (20). Comprehensive studies of viral
miRNAs revealed that they inhibit cytokine signaling, trafficking,
and release, which strongly suppresses the host immune response
(21, 22).
During HCMV lytic infection, host cells are influenced by
certain unique features associated with RNA processing. In
contrast to other viruses that induce shutdown of host mRNA
translation, HCMV stimulates this activity by blocking protein
kinase R activation (23) and modulates cellular RNA-processing
machinery to accelerate viral gene translation (24–26). Addition-
ally, viral mRNAs undergo extensive posttranscriptional modifi-
cations, such as alternative splicing and polyadenylation (27, 28),
with elevated expressions of proteins regulating such modifications
during HCMV infection (29, 30). Although these reports reveal
that HCMV might require cellular RNA-processing machinery for
efficient replication at multiple steps, how these RNA-binding pro-
teins regulate host mRNAs and cellular functions remains largely
unexplored.
In this study, we examined the role of cellular RNA-processing
proteins in immune regulation during HCMV lytic production
by employing loss-of-function screening. We found that 19 genes
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are required for HCMV lytic production, among which Roquin
was critical for viral gene expression. HCMV-induced Roquin
played a dominant role in the suppression of cytokine production.
During viral infection, Roquin directly bound to and regulated
expression of cellular RNA transcripts including those of cytokine
genes and IRF1, which was crucial for increased cytokine sup-
pression and enhanced viral replication. These results demon-
strated areas of HCMV evolution to exploit host RNA-binding
proteins in order to modulate the cellular environment in its favor.
Results
HCMV Requires Multiple Cellular RNA-Processing Activities for Its
Efficient Lytic Production. HCMV harbors multiple viral genes
that modulate cellular mRNA processing, with some host cell
genes capable of positively or negatively regulating viral infec-
tion. To identify genes essential for HCMV lytic production, an
RNA interference (RNAi)-screening experiment was performed
using 687 genes involved in cellular RNA processing. The small-
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Fig. 1. Identification of RNA-binding proteins that regulate HCMV lytic infection through siRNA screening. (A) Experimental scheme of siRNA screening.
RNases, RNA-binding proteins, and orthologous genes in the small-RNA pathway from C. elegans were collected for screening. HFF cells underwent two
rounds of siRNA transfection, with infection with HCMV (MOI = 2). Viral gene expression was measured by qRT-PCR at 48 hpi and normalized against GAPDH
mRNA levels. (B) Summarized results of RNAi screening. IE1, UL44, and UL99 mRNA levels were quantified. Genes showing a >threefold decrease are
highlighted in red. (C) Genes showing a >threefold decrease in UL99 mRNA level are selected. Heatmap of fold changes [log2(siTarget/siCon)] of viral mRNA
levels in cells depleted of each gene. (D) HCMV and HSV-1 viral replication as measured by plaque-forming assay. HFFs were infected with HCMV or HSV-1
(MOI = 0.1), and the cell-free supernatants were titrated at 7 dpi for HCMV and 2 dpi for HSV-1.































RNA-binding proteins, ribonucleases, and orthologs ofCaenorhabditis
elegans genes (Fig. 1A and Dataset S1). The gene information on
RNA-binding proteins in humans was obtained from the RNA-
binding Protein Database (31). The ribonuclease category in-
cluded previously reported and predicted ribonucleases based on
National Center for Biotechnology Information gene informa-
tion. The orthologous genes from C. elegans were collected from
candidate genes in the small RNA pathway (32) in order to in-
clude cellular genes containing neither an RNA-binding nor an
RNase domain. We employed transient loss-of-function screen-
ing using siRNA to minimize cellular damage and artifacts po-
tentially occurring as a result of genomic disruption. Additionally,
we used primary human foreskin fibroblasts (HFFs) and HCMV
low-passage strain Toledo to mimic the physiological environment
of HCMV infection for screening.
For RNAi screening, primary HFFs were transfected with
mixed siRNAs comprising four kinds of specific siRNAs target-
ing the open reading frame (ORF) regions at a final concen-
tration of 20 nM. At 2 d after transfection, the HFF cells were
infected with virus at a multiplicity of infection (MOI) of 2,
followed by treatment with the siRNA mixture again in order to
maximize knockdown efficiency. The level of viral lytic pro-
duction was quantified by detecting the mRNA levels of imme-
diate early (IE1), early (UL44), and late (UL99) genes at 48 h
postinfection (hpi) because most viral genes involved in lytic
production are actively expressed at this time point. Therefore, it
was expected that a functional gene influencing any phase of the
HCMV life cycle would be identified through RNAi screening
according to phase specificity. Screening returned 36 genes
exhibiting a >threefold decrease in mRNA levels for viral late
gene expression (Fig. 1B), with a majority of these genes also
required for efficient viral early gene expression (Fig. 1C). To
evaluate the effect on authentic viral production, secreted viruses
were examined at a low-titer infection (0.1 MOI). We found
that 19 genes exhibited a >10-fold decrease in viral production
(Fig. 1D), with most of these genes not previously reported as
having functions associated with viral production. Strikingly,
replication of herpes simplex virus (HSV)-1, which belongs to
the α-herpesvirus family, did not require these genes (Fig. 1D),
suggesting an HCMV-specific role of cellular RNA-processing
machinery. To identify the effect of the candidate genes on the
HCMV lytic life cycle, viral protein expression was examined during
a time-course infection accompanied by the transient knockdown of
three candidate genes,MBNL3, ASMTL, and CSE1L (SI Appendix,
Fig. S1), showing that viral gene expression was clearly repressed
at the late stage of the viral life cycle. Therefore, HCMV re-
quires multiple cellular genes involved in RNA processing, and
the 19 newly identified cellular genes are involved in HCMV lytic
production.
Roquin Is Essential for HCMV Lytic Production. Among the 19 can-
didate genes, we investigated the RNA-binding protein Roquin
(RC3H1) further. Human RC3H1 encodes the Roquin protein
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Fig. 2. Pivotal role of Roquin during HCMV lytic production. (A) HFF cells were infected with HCMV Toledo (MOI = 2) and harvested at the indicated time
points for immunoblot. HCMV was irradiated with UV-C (300 mJ/cm2) before infection. (B–F) HFF cells were treated with siCon or siRoq, infected with HCMV
(MOI = 2), and harvested at the indicated time points. (B and C) mRNA levels of Roquin (B) and viral genes IE2, UL44, and UL99 (C) were measured by qRT-PCR.
(D) Protein levels of various viral proteins and Roquin were measured by immunoblot. (E) Viral genomic DNA levels were measured in cells transfected with
two different siRNAs targeting Roquin. (F) Cell-free virus in the supernatant was titrated by limiting dilution analysis. Data represent mean ± SEM, n = 3; *P <
0.05 according to two-way ANOVA with Dunnett’s multiple comparisons test. (B, C, and E) Data represent mean ± SEM, n = 3; **P < 0.01; ***P <
0.001 according to two-tailed Student’s t test; NS, not significant.







































immunoregulatory role by targeting mRNA transcripts of several
proinflammatory cytokines and signaling genes (33–36). Roquin-
mediated cytokine control is crucial for T cell regulation (35),
but its physiological roles regarding host–pathogen interactions
have not been explored yet. We focused on Roquin based on its
expression being significantly induced during HCMV infection of
HFFs (Fig. 2A), as well as the absence of this induction during
UV-irradiated HCMV infection, where immediate early (IE2),
early (UL44), and late (UL99; pp28) viral gene expression was
completely blocked. The involvement of viral genes in Roquin
induction was further demonstrated by the absence of the in-
creased Roquin expression in cells depleted of IE1, the major
viral immediate early protein, which is necessary for the expression
of most HCMV genes (SI Appendix, Fig. S2A). Treatment of gan-
ciclovir, the viral DNA polymerase inhibitor repressing HCMV
late gene expression, did not alter the increased expression of
Roquin protein, implying that Roquin induction is mediated by
HCMV immediate early or early genes (SI Appendix, Fig. S2B).
We also observed that activation of cellular innate immune sig-
naling by transfection of poly(dA:dT) or poly(I:C) had no impact
on Roquin expression (SI Appendix, Fig. S2C). These results
suggested that Roquin expression is actively induced by viral genes
expressed during HCMV infection.
The impact of Roquin on viral replication was further exam-
ined during a detailed time-course infection of HFFs treated
with control (siCon) or Roquin-targeting siRNA (siRoq) to in-
duce transient knockdown of Roquin, after which the mRNA and
protein levels of the viral genes were analyzed by qRT-PCR and
immunoblot (Fig. 2 B–D). While Roquin expression was indeed
repressed by siRoq (Fig. 2 B and D), mRNA and protein levels of
viral IE2, UL44, and UL99 were also significantly down-
regulated by Roquin silencing, with this down-regulation peak-
ing at 72 hpi (Fig. 2 C and D). Reduction of several late tran-
scripts also demonstrated that Roquin is necessary for efficient
expression of viral genes (SI Appendix, Fig. S2D). We also ex-
amined the role of Regnase-1, which has redundant function
with Roquin (37). Protein levels of Regnase-1 were also in-
creased after 48 hpi, and Regnase-1 silencing resulted in re-
duction of viral gene expression (SI Appendix, Fig. S2E).
However, the impact of Regnase-1 on viral genes was lower than
that of Roquin, highlighting the pivotal role of Roquin during
HCMV infection.
The expression of viral late gene UL83 (pp65) was measured
in cells infected with two attenuated strains of HCMV (AD169
and Towne), revealing repressed UL83 expression in Roquin-
knockdown cells and indicating that Roquin function during in-
fection is conserved in multiple HCMV strains (SI Appendix, Fig.
S2F). Additionally, we found that viral genomic DNA levels that
had increased for up to 72 hpi were down-regulated by Roquin
knockdown (Fig. 2E). Viral titers measured in cell culture super-
natant also showed 10-fold decrease by Roquin silencing (Fig. 2F).
These results suggested Roquin as a cellular factor with a critical
role in HCMV lytic production, and that HCMV actively utilizes
Roquin for efficient viral production.
Roquin Silencing Results in Increased Production of Proinflammatory
Cytokines during HCMV Infection. To investigate how cellular genes
are regulated by Roquin during HCMV lytic replication, we
performed RNA-sequencing (seq) in HFFs treated with control
(siCon) or Roquin-targeting siRNA (siRoq) (38). The levels of
RNA from cellular genes were measured in uninfected cells
and HCMV-infected cells harvested at 6, 24, and 72 hpi, fol-
lowed by comparison according to siCon or siRoq transfection
and gene set enrichment analysis (GSEA) to examine the cel-
lular pathways modulated by Roquin. The results showed that
pathways related to the immune response and cytokine signaling
were significantly enriched for genes up-regulated by Roquin
knockdown (SI Appendix, Fig. S3 A and B and Dataset S2). We
then evaluated the time-course expression patterns of genes
from these pathways (Fig. 3A). In control cells, HCMV in-
fection induced global decreases in the expression of these
immune-related genes (Fig. 3A, lanes 1–4). Strikingly, upon
Roquin silencing, this inhibition was completely blocked, and
the expression of these genes was maintained at a high level (Fig.
3A, lanes 5–8 and 9–12). Moreover, the majority of these genes
exhibited a higher fold induction by Roquin knockdown as viral
replication proceeded, highlighting the role of Roquin through-
out the infection process (SI Appendix, Fig. S3C). These results
indicated that HCMV actively suppresses cellular immune re-
sponses during its lytic infection cycle by employing Roquin
function.
We confirmed the effect of Roquin on the expression of in-
dividual proinflammatory cytokine genes during HCMV in-
fection. mRNA levels were measured from Roquin-silenced cells
for genes encoding different cytokines (IL6, CSF3, and IL1B),
chemokines (CXCL2 and CCL2), interferons (IFNB and IFNA1),
and ISGs (MXA and RSAD2). mRNA expressions of these genes
showed a marked increase by Roquin silencing in uninfected cells.
However, this increase was further potentiated by HCMV infec-
tion, with cytokine levels showing >200-fold induction at 72 hpi
(Fig. 3B). Notably, although the expression of cytokines and
chemokines showed the highest increases at 72 hpi, IFN and ISG
genes showed robust induction at 24 hpi. Thus, Roquin controls
the expression of various antiviral genes at steady state to regulate
immune homeostasis, and its function is maintained throughout
the early and late phases of infection.
We then measured cytokine production in the supernatant of
infected cells using a multiplex cytokine bead assay. Secretion of
IL-6, IL-8, and tumor necrosis factor-α, which was increased upon
HCMV infection, was elevated further in Roquin-knockdown
cells and peaked at 72 hpi (Fig. 3C). Production of another
proinflammatory cytokine, VEGF, showed no significant differ-
ence by Roquin knockdown, indicating that Roquin function is
specific to a particular subset of immune-related genes.
To examine the impact of secreted cytokines on HCMV rep-
lication, we transferred the conditioned media harvested from
Roquin-silenced HFFs to naïve cells and measured viral gene
expression in the recipient cells (Fig. 3D). The media from
Roquin-silenced but uninfected donor cells could not affect viral
replication in the recipient cells (Fig. 3D, gray bars). Conversely,
viral gene expression was significantly reduced when incubated
with media from HCMV-infected, Roquin-silenced HFFs (Fig.
3D, red bars). Similar results were observed when recipient cells
were infected at higher MOI (SI Appendix, Fig. S3D). Thus, al-
though Roquin continually represses cytokine expression in un-
infected cells, Roquin’s impact is further magnified during viral
infection where antiviral cytokine levels are robustly induced.
Genome-Wide Identification of Roquin Target mRNAs during HCMV
Infection. Roquin down-regulates gene expression by directly
binding to the 3′ UTR of target mRNAs and controlling their
stability (39). RNA-seq data showed that Roquin mediated the
down-regulation of a number of genes during HCMV infection;
therefore, we identified the RNAs directly bound by Roquin by
cross-linking immunoprecipitation (CLIP)-seq analysis of un-
infected or HCMV-infected HFFs at 24 and 72 hpi using two
different antibodies (514a and 515a) (SI Appendix, Fig. S4A).
Both antibodies successfully captured endogenous Roquin pro-
tein and Roquin-bound RNA (SI Appendix, Fig. S4B). CLIP-seq
reads were mapped to the human or viral genome, which enabled
identification of between ∼4,000 and 60,000 binding sites from
each library (38). To define the Roquin target region, CLIP-seq
clusters were built from each time point by overlapping (by one
nucleotide) the libraries derived from the two different anti-
bodies. We obtained 7,068, 462, and 1,907 clusters from 0, 24,
and 72 hpi, respectively (SI Appendix, Fig. S4C and Dataset S3),































with >50% of the clusters located in the 3′UTR of cellular genes
(Fig. 4A), consistent with previous reports (37–40). Although the
majority of CLIP-seq clusters were mapped to the human ge-
nome, 23% and 9% of the clusters from 24 hpi and 72 hpi, re-
spectively, were mapped to transcripts from the viral genome,
indicating that Roquin can also bind to viral RNA molecules (SI
Appendix, Fig. S4D).
We then analyzed the structural characteristics of the Roquin-
binding sites. Secondary structure prediction using RNAfold (41)
identified various stem-loop structures enriched in the Roquin
CLIP-seq clusters from both noninfected or infected samples
(Fig. 4B and SI Appendix, Fig. S4E). A total of 20%, 21%, and
22% of Roquin-binding clusters contained these stem-loop
structures at 0, 24, and 72 hpi, respectively (SI Appendix, Fig.
S4F). Stem loops with a three-nucleotide loop were the most
common motif, and hairpins with longer stems were over-
represented. Given that no such enrichment of stem loops was
observed from CLIP-seq data associated with the Argonaute-
2 protein (22), enrichment of stem-loop structures likely repre-
sents a specific feature of Roquin-RNA binding. Sequences
comprising each stem-loop were aligned using WebLogo (42) in
order to identify sequence motifs (Fig. 4C). The results showed
that a UAU motif was highly enriched at the loop position with a
GC pair at the stem-initiation site. Although stem-loop struc-
tures involving a three-nucleotide loop and the GUAUC se-
quence represent a previously reported consensus binding motif
of Roquin (37, 39, 43, 44), we also observed that Roquin is ca-
pable of binding stem loops of various lengths and sequences.
We next assessed the ability of Roquin to inhibit expression of
target genes using RNA-seq data to measure fold changes in
their expression between siCon- and siRoq-transfected cells.
Compared with mRNAs not targeted by Roquin, mRNA levels
of Roquin targets showed significant accumulation in Roquin-
knockdown cells (Fig. 4D), indicating the degradative function
of Roquin. Additionally, we verified that target genes identified
from different CLIP-seq samples (noninfected, 24, or 72 hpi)
showed elevated expression both in the presence and absence of
viral infection (Fig. 4D). These results showed minimal changes
in the Roquin targetome by HCMV infection, thereby suggesting
that Roquin functions by down-regulating its target genes con-
sistently throughout the infection cycle.
While CLIP-seq data confirmed previously reported Roquin
targets such as IL6 and CXCL2, it also enabled identification of
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Fig. 3. Roquin knockdown results in increased expression of proinflammatory cytokines. (A) Heatmap of (log2TPM) immune-related gene expression at the
indicated time points in siCon or siRoq cells. (B) HFF cells were treated with siCon or siRoq, infected with HCMV (MOI = 2), and harvested at the indicated time
points. mRNA levels of immune-related genes were measured by qRT-PCR. (C) Cytokine levels from cell-culture supernatant were measured by multiplex
cytokine bead assay. (D) After siRNA transfection and HCMV infection (MOI = 2), cell culture supernatant (conditioned media; CM) was harvested at 72 hpi
and UV-irradiated to inactivate viral particles. Naïve HFFs were incubated with CM, infected with HCMV (MOI = 0.5), and harvested at 72 hpi. UL99 mRNA
level was measured by qRT-PCR. (B–D) Data represent mean ± SEM, n = 3; *P < 0.05; **P < 0.01; ***P < 0.001 according to two-tailed Student’s t test; NS, not
significant.







































processes, including DKK1, IRF2BPL, and MMP2 (SI Appendix,
Fig. S4 G and H). RNA IP verified Roquin binding to these
target mRNAs (Fig. 4E), which were accumulated in Roquin-
knockdown cells (Fig. 4F). Comparison of our Roquin targetome
with previous studies (37, 40) revealed that 43% of the target
genes identified in the present study overlapped with those
reported previously (SI Appendix, Fig. S4I). Notably, both tar-
get genes that are unique to this study and that overlapped with
previous reports were significantly up-regulated by Roquin si-
lencing. These findings provided further evidence that Roquin
selectively down-regulates target genes identified by CLIP-seq
during viral replication.
IRF1 Is a Major Roquin Target. To determine the specific Roquin
target(s) involved in HCMV gene expression, we combined our
Roquin CLIP-seq data with RNA-seq data from the Roquin-
knockdown cells and performed another RNAi-screening ex-
periment to evaluate the role(s) of Roquin targets (SI Appendix,
Fig. S5A). We selected 109 genes associated with Roquin-binding
peaks on their transcripts and increased expression upon Roquin
silencing. Each gene was silenced along with Roquin in order to
quantify changes in HCMV late gene (UL146) levels. Most of the
candidate genes conferred no effect on the repressed viral gene
expression induced by Roquin knockdown (Fig. 5A). However,
respective silencing of four genes (ANKRD52, CDK6, CFL2, and
IRF1) showed a >50% rescue of viral gene expression levels (Fig.
5A), implying that they are involved in reducing viral gene ex-
pression in Roquin-knockdown cells. Since IRF1 is a well-known
transcriptional activator of various cytokines (45), we assumed
that targeting IRF1 may be critical for Roquin-mediated control
of cytokine and HCMV replication.
CLIP-seq reads were mapped to the 5′ UTR region of IRF1
mRNA, and the binding sequences were predicted to contain a
hairpin structure with a three-nucleotide loop, consistent with
the consensus Roquin-binding site (Fig. 5B). This putative
Roquin target site was unexpected, given that previous reports
and our CLIP-seq data consistently showed that Roquin mainly
binds to the 3′ UTR of target mRNA (39, 40). We observed that
the levels of mRNAs harboring Roquin target sites in the 5′
UTR showed statistically significant up-regulation by Roquin
knockdown (SI Appendix, Fig. S5B), implying that both 5′ and 3′
UTRs represent functional target sites of Roquin. Furthermore,
we confirmed both that Roquin bound to IRF1mRNA throughout
the HCMV-infection process (Fig. 5C) as well the presence of up-
regulated levels of IRF1 protein in Roquin-knockdown cells (Fig.
5D). IRF1 was increased both in the absence and presence of
HCMV infection, indicating that Roquin constantly regulates
IRF1 expression. Our findings demonstrated that IRF1 represents
a target gene, the expression of which is suppressed by Roquin
during HCMV infection.
We next examined the impact of Roquin on viral gene and
IRF1 expression in THP-1–derived macrophages and glioblas-
toma U373MG cells. Similar to the results in HFFs, Roquin si-
lencing reduced viral gene expression in both cell lines, where







































































































































































































































































































































































































Fig. 4. Genome-wide identification of Roquin target genes. (A) Distribution of binding sites among RNA transcripts based on overlapped Roquin-binding
clusters. (B) Enrichment of indicated stem-loop structures in the Roquin-binding clusters as compared with 100 dinucleotide shuffles of each sequence. (C)
RNA sequences of Roquin-binding clusters comprising each indicated stem-loop structure. (D) Cumulative-distribution function plot of fold changes in CLIP
target genes identified at each time point and following Roquin silencing. P values were calculated using a two-sided Mann–Whitney U test. (E) Roquin
binding of the indicated mRNAs according to RNA IP. (F) RNA levels of CLIP target genes measured in Roquin-silenced cells by qRT-PCR. (E and F) Data
represent mean ± SEM, n = 3; *P < 0.05; **P < 0 .01; ***P < 0 .001 according to two-tailed Student’s t test; NS, not significant.































Roquin expression was increased by infection as well (SI Appendix,
Fig. S5 C and D). However, Roquin silencing increased IRF1 level
only in uninfected macrophages, implying that Roquin-mediated
IRF1 regulation during HCMV infection might be specific to fi-
broblasts. These data indicated that while Roquin is necessary for
lytic HCMV replication regardless of cell types, Roquin targetome
might differ between cell types.
Roquin-Mediated Down-Regulation of IRF1 Is Critical to Mediating
Cytokine Levels during HCMV Lytic Infection. We then evaluated
the role of Roquin-IRF1 axis in HCMV gene expression. HFF
cells were transfected with either siRoq alone or siRoq and
siRNA targeting IRF1 (siIRF1), followed by HCMV infection. We
confirmed that IRF1 levels were elevated by Roquin knockdown
and declined following siIRF1 transfection (Fig. 6A). Although
levels of the viral genes IE2, UL44, and pp28 were all repressed by
Roquin knockdown, they were rescued to control levels by IRF1
silencing. Viral production also showed significant increase when
IRF1 was cosilenced with Roquin (Fig. 6B), indicating that IRF1
down-regulation by Roquin is critical for successful replication
of HCMV.
IRF1 works as a transcription factor and regulates immune
responses primarily through the induction of proinflammatory
cytokines and promotion of antibacterial or antiviral immune
responses (45). Additionally, genome-wide ChIP-seq analysis
revealed putative IRF1-binding sites in the promoter regions of
numerous genes associated with apoptosis and DNA-damage
responses (46). To assess the role of Roquin and IRF1 on im-
mune responses during HCMV infection, we measured cytokine
production in cells with both genes silenced (Fig. 6C). We ob-
served significant increases in the mRNA levels of various cy-
tokines (IL6, CXCL2, and CCL2) and antiviral genes (IFNA1
and RSAD2) in Roquin-silenced cells, whereas these levels were
attenuated to >50% by cosilencing of IRF1 and Roquin. This
result suggested that cytokine regulation by Roquin during
HCMV infection was, in part, dependent upon IRF1.
To further determine the importance of IRF1 targeting by
Roquin, we blocked the interaction between Roquin and IRF1
mRNA specifically. We designed an antisense oligonucleotide
(ASO) targeting the stem region in order to disrupt hairpin
formation at Roquin-binding region, and a control ASO target-
ing a different region of the IRF1 5′ UTR in order to rule out the
translation-inhibition effect of the 5′ UTR-targeting oligonu-
cleotide (Fig. 6D). Transfection of cells with the stem loop-
targeting ASO resulted in increased IRF1 protein levels (Fig.
6D), suggesting that Roquin recognizes and binds to the stem-
loop region of the IRF1 5′ UTR to induce its down-regulation.
Additionally, when ASO-transfected cells were infected with
HCMV, the increased expression of IRF1 resulted in reduction
of viral gene expression (Fig. 6E). Therefore, we conclude that
Roquin represses IRF1 expression primarily to promote efficient
replication of HCMV.
Discussion
In recent decades, the functional relationship between DNA
viral infections and cellular RNA processing has been under-
estimated, and the associated mechanisms have remained largely
unknown. Our report of an immune-regulatory function for the
RNA-binding protein Roquin highlights the global requirement
of cellular RNA processing machinery during HCMV infection.
Loss-of-function screening using an siRNA library comprising
687 RNases or RNA-binding proteins identified 36 genes critical
for viral gene expression and 19 genes indispensable for HCMV
production. These genes showed no effect on HSV-1 replication,
indicating their role is specifically required for HCMV. Because
HCMV harbors a larger genome and a longer life cycle relative
to HSV-1 (47), it is presumed to manipulate a more diverse set
of cellular functions. Our screening results provide insight to
promote further investigation into how diverse RNA-metabolic


























































































































Fig. 5. IRF1 is a primary target of Roquin. (A) Relative expression of viral late gene (UL146) measured in HFFs transfected with indicated siRNA, infected with
HCMV (MOI = 2), and harvested at 72 hpi. Cells were transfected with siCon, siRoq, or cotransfected with siRoq and siRNAs targeting Roquin-binding targets
(siTarget). (B) Roquin-specific CLIP reads mapped to IRF1 mRNA and its predicted secondary structure. (C) RNA IP results confirming Roquin binding to
IRF1 mRNA (mean ± SEM, n = 3). (D) IRF1 protein levels measured by immunoblot from HFF cells treated with siCon or siRoq and infected with HCMV (MOI = 2).







































Cytokines are critical mediators of immune responses, and
their expression must be tightly controlled in order to simulta-
neously inhibit pathogen replication and prevent host damage.
HCMV actively induces massive alteration of IFN-responsive
genes and cytokine mRNA levels during lytic infection; however,
the mechanisms associated with this process remain unclear (48,
49). In the present study, we propose that Roquin is a key me-
diator of HCMV-induced immune regulation. We observed that
protein and mRNA levels of proinflammatory cytokines and
IFN-response molecules decreased over the duration of the in-
fection, and that this down-regulation was completely reversed
after blockage of Roquin induction (Fig. 3A). Expression levels
of the corresponding genes were greatly increased and main-
tained at high level throughout the infection, which may prevent
the successful replication of HCMV as shown in the conditioned
media experiment (Fig. 3D).
Intriguingly, the expression of Roquin is markedly induced
upon HCMV infection. Given the crucial role of Roquin in-
volved in inflammatory diseases and immune cell homeostasis
(33, 35), Roquin expression likely must be tightly regulated.
Viruses modulate the expression patterns of cellular genes for
their advantage, with HCMV reportedly inducing the altered
expression of thousands of cellular genes (50). A previous study
reported a threefold increase in peptides mapped to the Roquin
protein following infection with HCMV, although its biological
function was not addressed (51). Our data show that a specific
viral gene is responsible for Roquin induction as virus could not
induce Roquin after UV irradiation or IE1 knockdown. We as-
sume that HCMV evolved to actively amplify Roquin to survive
the proinflammatory cytokine storm during infection. Although
Roquin is able to regulate its target genes in uninfected cells,
immune-related genes are robustly increased by viral infection,
so the virus may require Roquin induction to successfully control
cytokines. Identification of this viral gene will help elucidate the
detailed mechanism associated with Roquin exploitation by HCMV.
We identified genome-wide Roquin-binding sites at both the
endogenous level and in virus-infected cells. The majority of
Roquin-binding transcripts were derived from the human ge-
nome, and the targetome showed no significant difference upon
HCMV infection. Roquin targets identified at a single time point
in CLIP-seq data appeared to undergo continuous regulation by
Roquin throughout the infection process (Fig. 4D). Our data
suggest that target genes and their associated molecular func-
tions are minimally altered by HCMV infection, but rather the
virus enhances Roquin function by increasing its expression.
Roquin CLIP-seq showed that most target regions were
mapped to the 3′ UTR of mRNAs, consistent with previous re-
ports (39, 52). However, we also found Roquin-binding sites
within 5′ UTRs or ORFs or introns of target genes, all of which
were able to induce down-regulation of the transcript (SI Appen-
dix, Fig. S5B). Moreover, ASO-mediated blocking of the Roquin-
binding site on IRF1 5′ UTR could prevent down-regulation (Fig.
6D), indicating that the targeted region of Roquin is not limited to
the 3′ UTR of mRNAs and that Roquin regulates target tran-
scripts at multiple binding sites.
CLIP-seq and RNA-seq analyses identified IRF1 as a key
Roquin target that plays a critical role in HCMV lytic infection.
IRF1 acts as a transcription factor that promotes the expression
of proinflammatory cytokines and IFNs. Our results showed that
cytokine levels increased following Roquin silencing, and that
this elevation was significantly reduced by cosilencing of IRF1
and Roquin. Moreover, we revealed that Roquin bound to and
down-regulated the expression of other transcripts, such as those





















































































































































































































Fig. 6. IRF1 regulates cytokine production during HCMV replication. (A–C) HFF cells were treated with siCon, siRoq, or siRoq+siIRF1 and infected with HCMV
(MOI = 2), followed by harvesting at 72 hpi. (A) Protein levels of Roquin, IRF1, and viral genes were measured by immunoblot. (B) Cell-free virus in the
supernatant was titrated by limiting dilution analysis. Data represent mean ± SEM, n = 3; ***P < 0 .001 (siCon versus siRoq; siRoq versus siRoq+siIRF1)
according to two-way ANOVA with Dunnett’s multiple comparisons test. (C) Cytokine mRNA levels were measured by qRT-PCR (mean ± SEM, n = 3; *P < 0.05;
**P < 0 .01; ***P < 0 .001 according to two-tailed Student’s t test; NS, not significant). (D) HFF cells were transfected with ASOs (at the indicated concen-
trations) targeting the Roquin-binding site on IRF1 mRNA, and IRF1 levels were measured by immunoblot. (E) HFF cells were transfected with ASOs and
infected with HCMV (MOI = 0.1). At 24 hpi, protein levels of IRF1 and viral gene (UL44) were measured by immunoblot.































signaling, suggesting that these targets might be involved in am-
plifying the immune-regulatory function of Roquin. This suggests
that in addition to posttranscriptional down-regulation of cellular
genes, Roquin also targets transcripts of transcription factors, in-
cluding IRF1, broadening its immune-regulatory function during
HCMV infection.
Apart from IRF1, we also discovered that depletion of three
Roquin target genes, ANKRD52, CDK6, and CFL2, could re-
verse Roquin-mediated reduction of viral late gene expression
(Fig. 5A). Although further experiments are required to confirm
Roquin’s impact on these genes, they may exert certain antiviral
functions, which are prevented by Roquin induction during
HCMV infection. ANKRD52 has been reported to promote
miRNA-dependent regulation through Argonaute dephosphor-
ylation (53), so Roquin may down-regulate its expression to in-
hibit cellular miRNAs involved in the innate antiviral responses
(54). Furthermore, HCMV may induce the suppression of
CDK6 and CFL2 to establish favorable cellular environment by
controlling cell cycle (55) and cytoskeleton dynamics (56), re-
spectively. Investigating the functions of the three genes would
provide further insight on various antiviral responses affecting
viral gene expression.
In summary, this study describes a HCMV-specific immune
evasion strategy involving the RNA-binding protein Roquin. Our
findings revealed the underlying mechanism associated with
HCMV-induced global suppression of proinflammatory cyto-
kines and antiviral genes, which had previously been observed
but not clearly explained. The results showed that Roquin si-
lencing resulted in activation of cytokine expression and delay of
viral production, thereby suggesting cellular RNA-binding pro-
tein may be targeted for CMV therapeutics. Furthermore, this
study emphasizes the importance of regulating RNA processing
during the DNA virus infection cycle. Future investigations will
target the role of other cellular RNA-binding proteins to eluci-
date other host–virus interactions involving RNA.
Materials and Methods
Cells and Viruses. Primary HFF cells (American Type Culture Collection [ATCC]),
HFFs immortalized with human telomerase, and glioblastoma U373MG cells
were grown at 37 °C/5% CO2 in Dulbecco’s Modified Eagle Medium (DMEM;
HyClone) with 10% Fetal Bovine Serum (FBS; HyClone), GlutaMAX-I (Gibco),
and penicillin-streptomycin (Gibco). THP-1 cells (ATCC) were cultured in
Roswell Park Memorial Institute medium (RPMI 1640; HyClone) supple-
mented with 10% FBS and GlutaMAX-I. Differentiation of THP-1 was in-
duced by treatment with 100 nM phorbol 12-myristate 13-acetate (PMA)
for 24 h.
Infectious virus particles of HCMV were generated by transfecting HCMV
Toledo-, AD169-, or Towne-BAC DNAs (gifts from T. Shenk; Princeton Uni-
versity, Princeton, NJ) into primary HFF cells via electroporation using Neon
(Invitrogen). When a 100% cytopathic effect was observed, cell culture
supernatants were harvested, centrifuged to remove cell debris, and stored
at −−80 °C in 1-mL aliquots. To titrate the viral stocks, HFFs grown on cover
glass were inoculated with diluted virus stocks for 1 h and fixed with 3.7%
formaldehyde at 24 hpi. Cells were then permeabilized using 0.1% Triton X-
100 and incubated in blocking buffer (2% BSA in PBS). Cells were stained
with HCMV IE1 antibody (MAB810R; Millipore), followed by FITC-conjugated
anti-mouse antibody (115-095-146; Jackson Laboratories), and mounted
with DAPI-containing solution (H-1200; Vector Laboratory). The number of
HCMV IE1-positive cells was counted, and the MOI was determined by cal-
culating the ratio of IE1-positive cells to total cells.
For viral infection, HFFs or U373MG cells were incubated with virus diluted
in serum-free DMEM for 1 h, washed with PBS, and incubated in complete
media for further experiments. PMA-differentiated THP-1 cells were in-
cubated with virus inoculum for 24 h, followed by PBS washing and in-
cubation in fresh media. For UV-irradiated virus, virus stock was irradiated at
300 mJ/cm2 on ice using a Spectrolinker (Spectroline). Ganciclovir (G2536;
Sigma) was treated at 5 μM after 1-h infection.
To measure viral production, naïve cells were incubated with serial dilutions
of cell culture supernatant from 1 to 5 hpi, and infectious units were measured
by counting IE1-positive cells using the same method explained above.
HSV-1 (a gift from J. H. Ahn; Sungkyunkwan University, Suwon, Republic of
Korea) was prepared and used as previously described (57). For plaque assay,
HFF cells were inoculated with serial dilutions of viruses and incubated with
methyl cellulose overlay. At 3 dpi for HSV-1 and 10–14 dpi for HCMV, cells
were stained with 1% crystal violet and plaques were counted.
DNA/RNA Transfection and RNAi Screening. HFFs or U373MG cells were
transfected with gene-specific siRNAs (siGenome; Dharmacon) or IE1 siRNA
(GCGGGAGAUGUGGAUGGCUdTdT; synthesized by Bioneer) usingDharmafect-
1 reagent (Dharmacon) at a final concentration of 20 nM. At 48 h post-
transfection, another set of siRNAs was transfected to effectively knock down
the target gene. The transfected cells were used for infection or subsequent
analysis after 24 h. THP-1 cells were treated with 100 nM PMA for 24 h, then
transfected with 40 nM siRNAs using Dharmafect-4 reagent (Dharmacon). Cells
were treated again with siRNA mixture at 24 h after first transfection, then
infected with HCMV after another 24 h. For stimulation of innate immune
response, HFFs were transfected with 1 μg/mL poly(dA:dT) (Sigma) or poly(I:C)
(Sigma) using Lipofectamine 3000 reagent (Invitrogen).
A total of 687 siRNAs for primary screening for RNA-processing proteins
(gene information provided in Dataset S1) and 109 genes for secondary
screening were obtained from the Dharmacon siGENOME library (Dharma-
con). For each gene, four specific siRNAs were designed and transfected as a
mixture. HFF cells were treated with siRNA for 48 h, infected with HCMV
Toledo at 2 MOI, and treated with secondary siRNA. For primary siRNA
screening, HFFs were transfected with 20 nM siRNAs and harvested at 48 hpi
for analysis of IE1, UL44, and UL99 mRNA levels. For secondary screening, a
total of 40 nM siRNAs was used for transfection (20 nM siRoq and 20 nM of
siTarget), and UL146 mRNA levels were measured at 72 hpi. mRNA levels
were quantified by qRT-PCR and normalized against GAPDH mRNA.
Other materials and methods used in this study are described in SI Ap-
pendix, SI Materials and Methods.
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